Identification |
Name: | 7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine,N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]- |
Synonyms: | N'-Cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine;Sch 79797 |
CAS: | 245520-69-8 |
Molecular Formula: | C23H25 N5 |
Molecular Weight: | 444.4 |
InChI: | InChI=1/C23H25N5.2ClH/c1-14(2)16-5-3-15(4-6-16)13-28-12-11-18-20(28)10-9-19-21(18)22(24)27-23(26-19)25-17-7-8-17;;/h3-6,9-12,14,17H,7-8,13H2,1-2H3,(H3,24,25,26,27);2*1H |
Molecular Structure: |
|
Properties |
Flash Point: | 364°C |
Boiling Point: | 678.3°Cat760mmHg |
Density: | g/cm3 |
Biological Activity: | Potent, selective non-peptide PAR 1 receptor antagonist (IC 50 = 70 nM). Inhibits haTRAP-induced- but not g-thrombin-, ADP- or collagen-induced human platelet aggregation. Also selectively blocks PAR 1 agonist- or thrombin-induced increases in cytosolic Ca 2+ in vascular smooth muscle cells. |
Flash Point: | 364°C |
Safety Data |
|
|